Matthew Feinstein, a Third Coast CFAR Pilot Awardee, will speak at the “HIV and CVD: Reducing Cardiovascular Risk in Patients with HIV/AIDS” event on March 17. With Priscilla Hsue, MD, FACC, they will address the specific need of cardiovascular practitioners, family practice physicians and infectious disease specialists to understand the importance of the intersection between cardiovascular disease (CVD) and HIV infection, the impact of antiretroviral therapy (ART) on cardiovascular (CV) risk, and the ability to implement recommended risk-reduction approaches to reduce the patients’ risk of CVD.
Recent Posts
- Johns Hopkins University CFAR Accepting Applications for HIV Implementation Science Training Program
- Northwestern’s Emerging and Re-emerging Pathogens Program Issues New Funding Opportunities for Infectious Diseases
- Depression and Anxiety Screening for People with HIV Paper Selected for Directors’ Choice
- Sexual and Gender Minority Research Featured at Chicago Pride Fest
- 2GETHER Relationship Education Intervention Endorsed by the CDC
- Northwestern Team Examines mHealth and Peer Navigation Combination Interventions to Roll Back the HIV Epidemic in Nigerian Youth